Viking Therapeutics Inc VKTX:NASDAQ

Last Price$2.71NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change-0.09(3.21%)
Bid (Size)$2.26 (4)
Ask (Size)$3.09 (5)
Day Low / High$2.67 - 2.82
Volume679.6 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/28/2022

 

Viking Therapeutics Inc ( NASDAQ )

Price: $2.71
Change: -0.09 (3.21%)
Volume: 679.6 K
4:00PM ET 6/28/2022
 
 

Xeris Biopharma Holdings Inc ( NASDAQ )

Price: $1.51
Change: -0.10 (6.21%)
Volume: 3.00
4:00PM ET 6/28/2022
 
 

Prophase Labs Inc ( NASDAQ )

Price: $13.24
Change: +0.26 (2.00%)
Volume: 421.8 K
4:00PM ET 6/28/2022
 
 

Concert Pharmaceuticals Inc ( NASDAQ )

Price: $4.72
Change: +0.14 (3.06%)
Volume: 108.00
4:00PM ET 6/28/2022
 
 

Aveo Pharmaceuticals Inc ( NASDAQ )

Price: $6.40
Change: -0.27 (4.05%)
Volume: 271.2 K
4:00PM ET 6/28/2022
 

Read more news Recent News

Insider Buy: Viking Therapeutics
5:33PM ET 5/03/2022 MT Newswires

Matthew W Foehr, Director, on May 02, 2022, executed a purchase for 45,000 shares in Viking Therapeutics (VKTX) for $111,195. Following the Form 4 filing...

--SVB Leerink Lowers Viking Therapeutics' Price Target to $12 From $18, Outperform Rating Kept
12:37PM ET 4/28/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Dragged Under After Investors Abandon Equities
3:54PM ET 2/10/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.3% and the SPDR Health Care Select Sector ETF (XLV) down...

Sector Update: Health Care
3:40PM ET 2/10/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.3% and the SPDR Health Care Select Sector ETF (XLV) down...

View all Commentary and Analysis

Viking Therapeutics' (VKTX) CEO Brian Lian on Q1 2022 Results - Earnings Call
10:49PM ET 4/27/2022 Seeking Alpha

Revisiting Viking Therapeutics
12:20PM ET 4/20/2022 Seeking Alpha

Viking Therapeutics (VKTX) Investor Presentation - Slideshow
12:45PM ET 3/14/2022 Seeking Alpha

Biotech 101 Lecture 3: Looking At Major Biotech Catalysts
3:23PM ET 3/08/2022 Seeking Alpha

Company Profile

Business DescriptionViking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The firm's clinical program, VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in the development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. View company web site for more details
Address9920 Pacific Heights Boulevard
San Diego, California 92121
Phone+1.858.704.4660
Number of Employees15
Recent SEC Filing05/26/20228-K
President, Chief Executive Officer & DirectorBrian Lian
Chief Operating OfficerMarianne Mancini
Chief Financial OfficerGregory S. Zante
Vice President-Finance & AdministrationMichael Morneau

Company Highlights

Price Open$2.79
Previous Close$2.71
52 Week Range$2.02 - 7.20
Market Capitalization$209.7 M
Shares Outstanding77.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement07/27/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.74
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-27.77%

Analyst Ratings as of 01/11/2022

Buy
9
Overweight
1
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset